我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

微小RNAs与新生血管形成

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2015年第1期
页码:
102-105,109
栏目:
综述
出版日期:
2014-09-25

文章信息/Info

Title:
MicroRNAs and angiogenesis
作者:
杨子岩2; 晏贤春1; 赵星成1; 张 萍1; 韩 骅1
(第四军医大学：1.医学遗传学与发育生物学教研室，2.学员旅，陕西 西安 710032）
Author(s):
YANG Zi-yan2;  YAN Xian-chun21;  ZHAO Xing-cheng1;  ZHANG Ping1;  HAN Hua1
(1.Department of Medical Genetics and Developmental Biology, 2.Cadet Brigade, Fourth Military Medical University, Xi’an 710032, Shaanxi, China)
关键词:
新生血管生成; microRNA; 调节网络; 靶基因
Keywords:
angiogenesis;  microRNAs;  networks;  target genes
分类号:
R394.1；R331.32
DOI:
-
文献标识码:
A
摘要:
新生血管形成是一种复杂的动态过程，其是在原有血管基础上通过促血管生成途径以及抗血管生成途径之间严密的协同作用而形成的。促血管生成途径与抗血管生成途径之间的平衡一旦被打破，则可导致病理性的新生血管形成，参与到肿瘤、炎症、心血管疾病等多种疾病的发生发展过程中。微小RNAs(miRNAs)可在mRNA和蛋白质水平调节基因表达，是细胞生命活动中重要的小分子调节物质。不同的miRNAs通过对特定靶基因的调节，在新生血管形成中发挥着重要作用。本文将就调控新生血管形成的重要miRNAs及其潜在的临床应用价值做一综述。
Abstract:
Angiogenesis is a complex process during which new vessels shape from pre-existing vasculature by a collaboration of pro- and anti-angiogenic signaling pathways. However, in pathological situations, the same angiogenic signaling pathways are dysregulated and exploited, typically resulting in cancer, inflammation and other cardiovascular diseases. MicroRNAs have emerged as a novel class of endogenous, small and non-coding RNAs that negatively regulate gene expression via degradation or translational inhibition of mRNAs and proteins. Recent studies have illustrated that microRNAs play incomparable roles in angiogenesis via regulating vascular cell differentiation, migration, proliferation and apoptosis through their target genes. This review summarizes the latest insights in the identification of vascular-specific microRNAs and discusses their potential clinical applications in vascular diseases.

参考文献/References

[1]Chang SH,Hla T.Gene regulation by RNA binding proteins and microRNAs in angiogenesis[J].Trends Mol Med,2011,17(11):650-658.
[2]Anand S.A brief primer on microRNAs and their roles in angiogenesis[J].Vasc Cell,2013,5(1):2.
[3]Treiber T,Treiber N,Meister G.Regulation of microRNA biogenesis and function[J].Thromb Haemost,2012,107(4):605-610.
[4]Guo H,Ingolia NT,Weissman JS,et al.Mammalian microRNAs predominantly act to decrease target mRNA levels[J].Nature,2010,466(738):835-840.
[5]Caporali A,Emanueli C.MicroRNA regulation in angiogenesis[J].Vascul Pharmacol,2011,55(4):79-86.
[6]Suarez Y,Sessa WC.MicroRNAs as novel regulators of angiogenesis[J].Circ Res,2009,104(4):442-454.
[7]Plummer PN,Freeman R,Taft RJ,et al.MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells[J].Cancer Res,2013,73(1):341-352.
[8]Xiao F,Qiu H,Zhou L,et al.WSS25 inhibits Dicer,downregulating microRNA-210,which targets Ephrin-A3,to suppress human microvascular endothelial cell(HMEC-1)tube formation[J].Glycobiology,2013,23(5):524-535.
[9]Landskroner-Eiger S,Moneke I,Sessa WC.miRNAs as modulators of angiogenesis[J].Cold Spring Harb Perspect Med,2013,3(2):a006643.
[10]Hartmann D,Thum T.MicroRNAs and vascular(dys)function[J].Vascul Pharmacol,2011,55(4):92-105.
[11]Anand S,Cheresh DA.Emerging role of Micro-RNAs in the regulation of angiogenesis[J].Genes Cancer,2011,2(12):1134-1138.
[12]Jin W,Reddy MA,Chen Z,et al.Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cells[J].J Biol Chem,2012,287(19):15672-15683.
[13]Fasanaro P,D Alessandra Y,Di Stefano V,et al.MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3［J］. J Biol Chem, 2008, 283(23):15878-15883.
[14]Dews M, Homayouni A, Yu D, et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster［J］. Nat Genet, 2006, 38(9):1060-1065.
[15]Doebele C, Bonauer A, Fischer A, et al. Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells［J］. Blood, 2010, 115(23):4944-4950.
[16]Fang Y, Shi C, Manduchi E, et al. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro[J].Proc Natl Acad Sci U S A,2010,107(30):13450-13455.
[17]Dentelli P,Rosso A,Orso F,et al.microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5a expression[J].Arterioscler Thromb Vasc Biol,2010,30(8):1562-1568.
[18]Wang XH,Qian RZ,Zhang W,et al.MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats[J].Clin Exp Pharmacol Physiol,2009,36(2):181-188.
[19]Jamaluddin MS,Weakley SM,Zhang L,et al.miRNAs:roles and clinical applications in vascular disease[J].Expert Rev Mol Diagn,2011,11(1):79-89.
[20]Yancopoulos GD.Clinical application of therapies targeting VEGF[J].Cell,2010,143(1):13-16.

备注/Memo

备注/Memo:
收稿日期：2014-03-05.
基金项目：国家自然科学基金项目资助(31370769)
通讯作者：张萍，讲师，主要从事血管发育基础医学研究Email：pingzhang0622@126.com
作者简介：杨子岩，本科生Email：yangziyan93@163.com
更新日期/Last Update: 2015-01-20